This contract expires in 176 days (Dec 31, 2026).
RLS (USA) INC. - NUCLEAR MEDICINE RADIOPHARMACEUTICALS
Key Details
Description
NUCLEAR MEDICINE RADIOPHARMACEUTICALS
Context & Analysis
On Nov 17, 2025, Department of Veterans Affairs obligated $165,401 to RLS (USA) INC. for nuclear medicine radiopharmaceuticals. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: competed under sap with 2 offers received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in LAKE MARY, FL. The contract is scheduled through Dec 31, 2026 — approximately 6 months remaining. This award is one of several similar procurements from Department of Veterans Affairs under NAICS 325412 — related awards are listed below.
Contractor Information
Similar Awards
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
MCKESSON CORPORATION
$1.4B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER
MCKESSON CORPORATION
$1.2B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER
MCKESSON CORPORATION
$1.1B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY
MCKESSON CORPORATION
$1.1B
LENALIDOMIDE FOR THE SALISBURY VAMC, CHARLOTTE HCC, AND KERNERSVILLE HCC.
EXELAN PHARMACEUTICALS INC
$5.1M
Stay Updated
Get notified about new opportunities matching your interests.